Lates News

date
03/09/2025
Before the market opening on Tuesday, the stock price of Novo Nordisk rose slightly. Previous reports indicated that the company's Novo Engage had a significantly better cardiovascular protective effect on participants compared to the competing products Mounjaro and Zepbound from Eli Lilly.